文献速递白血病

STING对RUNX1::RUNX1T1白血病细胞的存活至关重要

STING is crucial for the survival of RUNX1::RUNX1T1 leukemia cells.
PubMed 文献 · Leukemia · 2024-08-23

伴RUNX1::RUNX1T1(AE)融合的急性髓系白血病(AML)患者虽预后相对较好,但约50%在2.5年内复发并对后续化疗耐药。本研究显示,遗传学和药理学抑制STING均可减少AE白血病细胞;在小鼠原发AE白血病模型中,STING缺失显著减弱白血病生成并延长动物寿命。全基因组CRISPR筛选发现FADS2是STING抑制下游介导细胞死亡的非经典因子,STING抑制释放FADS2活性,诱导多不饱和脂肪酸(PUFAs)合成并触发脂质过氧化相关细胞死亡。

要点

  • 遗传学和药理学抑制STING均能减少AE白血病细胞。
  • 小鼠原发AE白血病模型中STING缺失显著减弱白血病生成并延长寿命。
  • STING抑制通过释放FADS2活性、诱导PUFAs合成触发脂质过氧化相关细胞死亡。

核心结论

  • STING在AE阳性AML细胞存活中起关键作用,并提示STING可作为这些患者临床干预的潜在治疗靶点。

研究设计与样本

  • 研究采用遗传学和药理学抑制STING、小鼠原发AE白血病模型及全基因组CRISPR筛选。

主要发现

  • 遗传学和药理学抑制STING均导致AE白血病细胞减少。
  • 小鼠原发AE白血病模型中STING缺失显著减弱白血病生成并延长动物寿命。
  • 阻断STING下游炎症通路在AE白血病细胞中产生与STING抑制相似的效果。
  • 全基因组CRISPR筛选鉴定FADS2为STING抑制下游介导细胞死亡的非经典因子。
  • STING抑制释放FADS2活性,诱导PUFAs合成并触发脂质过氧化相关细胞死亡。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Even though acute myeloid leukemia (AML) patients with a RUNX1::RUNX1T1 (AE) fusion have a relatively favorable prognosis, approximately 50% relapse within 2.5 years and develop resistance to subsequent chemotherapy [1]. It is therefore imperative to identify novel therapeutic targets for AE leukemia to improve outcomes. In this study, we unveil that targeting STING effectively suppresses the growth of AE leukemia cells. Both genetic and pharmacological inhibition of STING lead to the diminish of AE leukemia cells. Importantly, in a mouse primary AE leukemia model, STING deletion significantly attenuates leukemogenesis and prolongs the animals' lifespan. Blocking the downstream inflammatory pathway of STING yields similar effects to STING inhibition in AE leukemia cells, highlighting the pivotal role of STING-dependent inflammatory responses in sustaining the survival of AE leukemia cells. Moreover, through a genome-wide CRISPR screen, we identified fatty acid desaturase 2 (FADS2) as a non-canonical factor downstream of STING inhibition that mediates cell death. Inhibition of STING releases FADS2 activity, consequently inducing the synthesis of polyunsaturated fatty acids (PUFAs) and triggering lipid peroxidation-associated cell death [2]. Taken together, these findings reveal a critical function of STING in the survival of AE-positive AML cells and suggest STING to be a potential therapeutic target for clinical intervention in these patients.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Sun Y, Wu Y, Pang G, et al. STING is crucial for the survival of RUNX1::RUNX1T1 leukemia cells. Leukemia. 2024. PMID: 39179670. doi:10.1038/s41375-024-02383-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。